Interrater agreement for bruise detection was over 90% for all but two ALS wavelength/goggle combinations. Kappa values indicated adequate interrater agreement under white light (κ = 0.76) and ALS (κ = 0.78). The visibility scale intraclass correlation coefficients were .91 for normal light and .93 for ALS. Statistical modeling showed greater bruise size was associated with higher visibility using either scale, and greater contrast in color or lightness was associated with higher Bruise Visibility Scale values. Both visibility scales showed satisfactory reliability and validity. Forensic nurses can use the scales to consistently document bruises. Both visibility scales showed satisfactory reliability and validity. Forensic nurses can use the scales to consistently document bruises. Glenoid component loosening has remained one of the most common complications for total shoulder arthroplasty. Three-dimensional modeling of the glenoid may reveal novel information regarding glenoid vault morphology, providing a foundation for implant designs that possess the potential to extend the survivorship of the prosthesis. A three-dimensional digitizer was used to digitize the glenoids of 70 cadaveric scapulae. We identified ideal position, fit, and maximum diameter for cylinders of 5, 10, and 15 mm depths. Maximum diameter and volume were also measured at the glenoid center, and the data were compared. The vault region that accommodates the greatest diameter and volume for 5, 10, and 15 mm depth cylinders were identified in the postero-inferior glenoid. Across all specimens, this region accommodated a cylinder diameter that was 24.82%, 40.45%, and 50.34% greater than that achieved at the glenoid center for 5, 10, and 15 mm depth cylinders, respectively (all, P < 0.0001). The location of thitomy, providing a foundation for alternative approaches to glenoid prosthesis fixation in total shoulder arthroplasty and related procedures. The Altmetric Attention Score (AAS) has been associated with citation rates across medical and surgical disciplines. However, factors that drive high AAS remain poorly understood and there remains multiple pitfalls to correlating these metrics alone with the quality of a study. The purpose of the current study was to determine the relationship between methodologic and study biases and the AAS in randomized controlled trials (RCTs) published in total joint arthroplasty journals. All RCTs from 2016 published in The Journal of Arthroplasty, The Bone and Joint Journal, The Journal of Bone and Joint Surgery, Clinical Orthopedics and Related Research, The Journal of Knee Surgery, Hip International, and Acta Orthopaedica were extracted. Methodologic bias was graded with the JADAD scale, whereas study bias was graded with the Cochrane risk of bias tool for RCTs. Publication characteristics, social media attention (Facebook, Twitter, and Mendeley), AAS, citation rates, and bias were analyzed. A total of 42 artic these articles before making changes to clinical practice. High methodologic quality and limited study bias markedly contribute to the AAS of RCTs in the total joint arthroplasty literature. The AAS may be used as a proxy measure of scientific quality for RCTs, although readers should still critically appraise these articles before making changes to clinical practice. There continues to be a need for HIV prevention options that women can initiate and use autonomously. The dapivirine vaginal ring (VR) has been shown to have a favorable safety profile and reduce the risk of HIV-1 acquisition. We report on women's experiences with VR adherence during the MTN-025/HIV Open-label Prevention Extension (HOPE) study and responses to Residual Drug Level (RDL) results. Ten women at each of the 6 HOPE research sites in Lilongwe, Malawi; Durban (2 sites) and Johannesburg, South Africa; Kampala, Uganda; and Chitungwiza, Zimbabwe, were randomly selected (n = 60). After confirmation of eligibility criteria, in-depth interviews were conducted where available RDL results were presented. Many women with low RDL release measurements deflected blame onto other factors (the ring, the drug, and faulty testing machines) and distrust of the testing method. The disclosure of RDL results enabled some users to discuss their challenges experienced (fear of partner objections, perceived side efm to discuss their experiences. The aim of the article is to present recent epidemiological, microbiological, and clinical data for the surgical, antimicrobial, and adjunctive management of necrotizing soft-tissue infections (NSTI). NSTI can be caused by a broad variety of organisms. Reports about NSTI caused by multidrug-resistant bacteria are increasing. Owing to the rareness of NSTI, general clinical awareness is low and prompt diagnosis is often delayed. New diagnostic instruments (scoring systems, MRI) have either a low accuracy or are time consuming and cannot guide clinicians reliable currently. The value of adjunctive measures (intravenous immunoglobulin, hyperbaric oxygen therapy) is uncertain as well. Morbidity and mortality in NSTI remain high, ranging from 20 up to over 30%. Early radical surgical debridement and empirical broad-spectrum antimicrobial treatment remain the cornerstones of therapy in NSTI. Further clinical research is necessary to shorten diagnostic pathways and to optimize surgical, antimicrobial, and adjunctive treatment. Early radical surgical debridement and empirical broad-spectrum antimicrobial treatment remain the cornerstones of therapy in NSTI. https://www.selleckchem.com/products/nx-2127.html Further clinical research is necessary to shorten diagnostic pathways and to optimize surgical, antimicrobial, and adjunctive treatment. The aim of this study was to present recent microbiological, experimental, clinical and tolerance data for cotrimoxazole and clindamycin in the specific field of skin and soft tissue infections (SSTIs). Staphylococcus aureus and streptococci remain the leading cause of SSTIs. Cotrimoxazole is a good anti-Gram-positive agent with preserved activity against methicillin-susceptible and methicillin-resistant S. aureus (MRSA) and streptococci. Although clindamycin has good methicillin-susceptible S. aureus activity, a growing number of resistant MRSA and streptococci have been reported. Strong experimental data support the antitoxin activity of clindamycin, but clinical observations remain scarce. Several recent randomized trials involving cotrimoxazole and/or clindamycin demonstrate the efficacy and tolerance of both drugs. The oral formulation of both drugs may facilitate the implementation of early switch and early discharge protocols in clinical practice. Recent publications demonstrate that cotrimoxazole and clindamycin remain reliable and realistic therapeutic approaches for SSTIs.